Patrick Soon-Shiong, MD, CEO of ImmunityBio, discusses the pandemic as a unique moment in world & American history.
Segment Description: Patrick Soon-Shiong, MD, Chairman & CEO of ImmunityBio, discusses the pandemic as a unique moment in world & American history.
Part 1:
Patrick Soon-Shiong, MD, Chairman & CEO of ImmunityBio, explains why the firm's SARS-CoV-2 vaccine candidate uses Nucleocapsid DNA alongside Spike DNA.
Part 2:
Patrick Soon-Shiong, MD, Chairman & CEO of ImmunityBio, describes goals and expectations for the accelerated coronavirus vaccine program Operation Warp Speed.
Related Coverage: Racial Disparities in Coronavirus Incidence, Knowledge, and Exposure
A recent US survey showed African American men were more likely to know someone infected by COVID-19, had a greater knowledge disparity of how the virus spread, and were more likely to be exposed to the virus.
Marcella Alsan, MD, MPH, PhD, associate professor of medicine, Stanford University, led a team of investigators who developed the survey and analyzed the results. The survey’s findings were reported in JAMA.
Read the
Related Coverage: Inadequate Insurance Coverage Drives COVID-19 Racial & Economic Disparities
While calls for racial justice have reached a groundswell in recent weeks, it is clear from the COVID-19 pandemic and response that many health care inequities tied to both race and cross-racial economic factors are a long way from resolution.
According to Johns Hopkins University as of June 12, roughly 2,029,037 individuals have been confirmed to have contracted SARS-CoV-2. Even outside the most concerning pools of individuals at high-risk for severe infection, the outbreak carries risks for substantial financial consequences for any American hospitalized or kept out of work.
Read the
